Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$66.25 +0.79 (+1.21%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Current Assets (2010 - 2026)

Updated

Arrowhead Pharmaceuticals' Current Assets came in at $1.67 billion for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 76.5% from $946.92 million a year earlier but down 9.2% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Current Assets was $950.64 million, up 36.7% from FY2024.

  • Current Assets has increased in each of the last eight fiscal years, with a five-year compound annual growth rate of 24.1% (FY2020 to FY2025).
  • Going back by fiscal year, Current Assets was $695.47 million in FY2024 (+67.0%), $416.47 million in FY2023 (+2.8%), $405.3 million in FY2022 (+5.4%) and $384.6 million in FY2021 (+19.3%).
  • The five-year range for quarterly Current Assets is $237.9 million (fiscal Q1 2024) to $1.84 billion (fiscal Q2 2026).
  • Year-over-year, Current Assets has increased for eight consecutive quarters, with growth averaging 88.5% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in fiscal Q1 2025 (growth of 139.8%), and the weakest in fiscal Q1 2024 (a decline of 58.6%).
  • Business Quant data shows ARWR's Current Assets at $1.84 billion (Q2 2026), $1.17 billion (Q1 2026) and $950.64 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 1.67 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.67 Bn
Mar 31, 2026 1.84 Bn
Dec 31, 2025 1.17 Bn
Sep 30, 2025 950.64 Mn
Jun 30, 2025 946.92 Mn
Mar 31, 2025 1.14 Bn
Dec 31, 2024 570.54 Mn
Sep 30, 2024 695.47 Mn
Jun 30, 2024 450.06 Mn
Mar 31, 2024 541.65 Mn
Dec 31, 2023 237.90 Mn
Sep 30, 2023 416.47 Mn
Jun 30, 2023 470.17 Mn
Mar 31, 2023 574.81 Mn
Dec 31, 2022 575.00 Mn
Sep 30, 2022 405.30 Mn
Jun 30, 2022 432.39 Mn
Mar 31, 2022 417.63 Mn
Dec 31, 2021 338.28 Mn
Sep 30, 2021 384.60 Mn
API Access

Arrowhead Pharmaceuticals Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ARWR&period=max&api_key=YOUR_API_KEY